ADARx Pharmaceuticals, Inc. ADRX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 427.25M | 455.82M | 480.00M | 480.00M | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 14.29M | 12.90M | 13.38M | 13.38M | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 441.54M | 468.72M | 493.38M | 493.38M | -- |
|
|
|||||
| Total Current Assets | 441.54M | 468.72M | 493.38M | 493.38M | -- |
| Net Property, Plant & Equipment | 10.98M | 11.60M | 12.07M | 12.07M | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.81M | 2.24M | 2.21M | 2.21M | -- |
| Total Assets | 456.33M | 482.56M | 507.66M | 507.66M | -- |
|
|
|||||
| Total Accounts Payable | 4.86M | 6.77M | 5.84M | 5.84M | -- |
| Total Accrued Expenses | 8.53M | 6.35M | 6.37M | 6.37M | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.71M | 1.71M | 1.71M | 1.71M | -- |
| Total Finance Division Other Current Liabilities | 18.91M | 14.92M | 16.56M | 16.56M | -- |
| Total Other Current Liabilities | 18.91M | 14.92M | 16.56M | 16.56M | -- |
| Total Current Liabilities | 34.01M | 29.76M | 30.49M | 30.49M | -- |
|
|
|||||
| Total Current Liabilities | 34.01M | 29.76M | 30.49M | 30.49M | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 5.19M | 5.62M | 6.03M | 6.03M | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 310.56M | 315.30M | 315.78M | 315.78M | -- |
| Total Liabilities | 349.76M | 350.67M | 352.29M | 352.29M | -- |
|
|
|||||
| Common Stock & APIC | 18.86M | 17.33M | 16.49M | 16.49M | -- |
| Retained Earnings | -269.13M | -243.37M | -220.70M | -220.70M | -- |
| Treasury Stock & Other | -783.00K | 306.00K | 1.96M | 1.96M | -- |
| Total Common Equity | -251.05M | -225.73M | -202.26M | -202.26M | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 357.62M | 357.62M | 357.62M | 357.62M | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 357.62M | 357.62M | 357.62M | 357.62M | -- |
|
|
|||||
| Total Common Equity | -251.05M | -225.73M | -202.26M | -202.26M | -- |
| Total Preferred Equity | 357.62M | 357.62M | 357.62M | 357.62M | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 106.57M | 131.89M | 155.37M | 155.37M | -- |
|
|
|||||